{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:48:11Z","timestamp":1790135291373,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","award":["B-9005"],"award-info":[{"award-number":["B-9005"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.micpath.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T13:32:42Z","timestamp":1510493562000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis"],"prefix":"10.1016","volume":"114","author":[{"given":"Zakaria","family":"Bameri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Asadi Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-2008","authenticated-orcid":false,"given":"Parastoo","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2017.11.015_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(02)00470-4","article-title":"Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997\u20132000)","volume":"44","author":"Gales","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.11.015_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.11.015_bib3","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/infdis\/136.Supplement.S151","article-title":"Epidemiology of nosocomial infections due to gram-negative bacilli: aspects relevant to development and use of vaccines","volume":"136","author":"Stamm","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.11.015_bib4","series-title":"The Special Affinity of Particular Types of. P mirabilis","author":"Senior","year":"1978"},{"key":"10.1016\/j.micpath.2017.11.015_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ni0404-451","article-title":"Corrigendum: Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility","volume":"5","author":"Smith","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S1517-83822008000100011","article-title":"Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins","volume":"39","author":"Braga","year":"2008","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.micpath.2017.11.015_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/.61.1.65-89.1997","article-title":"Potential virulence factors of Proteus bacilli","volume":"61","author":"R\u00f3zalski","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.micpath.2017.11.015_bib8","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1128\/IAI.62.8.3363-3371.1994","article-title":"Construction of an MR\/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection","volume":"62","author":"Bahrani","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/IAI.72.1.66-75.2004","article-title":"Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis","volume":"72","author":"Li","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib10","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/IAI.67.6.2822-2833.1999","article-title":"Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis","volume":"67","author":"Li","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","article-title":"Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice","volume":"31","author":"Karam","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2017.11.015_bib12","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/eji.200425403","article-title":"Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1","volume":"34","author":"Cunningham","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib13","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1128\/IAI.72.11.6676-6679.2004","article-title":"Mucosal administration of flagellin induces innate immunity in the mouse lung","volume":"72","author":"Honko","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.181.3.2036","article-title":"Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity","volume":"181","author":"Nempont","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib15","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mad.2008.01.009","article-title":"Mucosal adjuvant activity of flagellin in aged mice","volume":"129","author":"Bates","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.micpath.2017.11.015_bib17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/IAI.00806-09","article-title":"Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines","volume":"78","author":"Campod\u00f3nico","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.micpath.2017.11.015_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.micpath.2017.11.015_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","article-title":"Recognition of errors in three-dimensional structures of proteins","volume":"17","author":"Sippl","year":"1993","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.micpath.2017.11.015_bib21","series-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.micpath.2017.11.015_bib22","first-page":"55","article-title":"Cloning of fimH and fliC and expression of the fusion protein FimH\/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran","volume":"4","author":"Asadi","year":"2012","journal-title":"IJM"},{"key":"10.1016\/j.micpath.2017.11.015_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pep.2005.09.027","article-title":"Single step protocol to purify recombinant proteins with low endotoxin contents","volume":"46","author":"Reichelt","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.micpath.2017.11.015_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2017.11.015_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molimm.2014.12.008","article-title":"Intranasal immunization with fusion protein MrpH\u00b7 FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis","volume":"64","author":"Habibi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-8579(02)00102-4","article-title":"Vaccines for Proteus mirabilis in urinary tract infection","volume":"19","author":"Li","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2017.11.015_bib27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00299-011-1065-3","article-title":"Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches","volume":"30","author":"Soria-Guerra","year":"2011","journal-title":"Plant Cell Rep."},{"key":"10.1016\/j.micpath.2017.11.015_bib28","first-page":"00312","article-title":"Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella Typhimurium flagellin","volume":"CVI","author":"Leal","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2017.11.015_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2013.09.088","article-title":"An Eimeria vaccine candidate based on Eimeria tenella immune mapped protein 1 and the TLR-5 agonist Salmonella typhimurium FliC flagellin","volume":"440","author":"Yin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2017.11.015_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/599839","article-title":"A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli","volume":"200","author":"Billips","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.11.015_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rvsc.2013.07.015","article-title":"Recombinant flagellin and its cross-talk with lipopolysaccharide\u2013Effect on pooled chicken peripheral blood mononuclear cells","volume":"95","author":"Gupta","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.micpath.2017.11.015_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065964","article-title":"The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon","volume":"8","author":"Knudsen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2017.11.015_bib33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.11.015_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2015.05.027","article-title":"Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model","volume":"28","author":"Habibi","year":"2015","journal-title":"Int. Immunopharmacol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401017313633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401017313633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:03:42Z","timestamp":1603303422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401017313633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"alternative-id":["S0882401017313633"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2017.11.015","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2017.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}